4d Pharma Share Discussion Threads

[thresholdbypass] 21/10/2020 12:59

You need to work on your timing conradj1, you're about two weeks late

[conradj1] 21/10/2020 12:56

timberrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr

[thresholdbypass] 21/10/2020 12:55

And kcow, I understand the sentiment, but some things cannot be managed. And I mean, were you this disilusioned when the price was 35p? Something is up, and whatever it is, it will drive the price up in the not so distant future, or this whole thing is going nowhere. Which one do you think?

[thresholdbypass] 21/10/2020 12:49

And he is only ever here when the numbers are red, now why would that be? It is such a mysterie...

[gooner1886] 21/10/2020 12:44

Mr wilkes opened a short in 4d at 110p (His own admittance) It shot up to about 165p 3 days later...He is skint! What a muppet

[thresholdbypass] 21/10/2020 12:34

Dear Mr Wilkes, you know nothing about that either, you might be right, but there's nothing to say that lot's of short term traders did not simply cash in and the next move is a partnership. We'll see, but if you are right it does not mean you know more than anyone else. If it was that easy, you wouldn't be here, but somewhere enjoying your millions, which you obviously are not

[the stigologist] 21/10/2020 12:32

Tell you what maybe go all in on it with your pension you noob?

[ronwilkes123] 21/10/2020 12:21

Forward selling a placing with shorts in the know involved - we've all seen it before

[devonlad] 21/10/2020 12:15

Yup, the moves are dictated by the bots, they control it completely. what you post on here makes no difference at all! Just look at the trades and when it moves, always an AT trade pushing it one way or another.

[thresholdbypass] 21/10/2020 12:11

Anyone who thinks that posting on this board can influence the share price knows absolutely nothing about the market

[stigofthedump] 21/10/2020 12:09

got a lot of hot entries in the 80ps..im expecting to see this domino into 70ps

bears in full control

[katsy] 21/10/2020 12:06

next the gap. 9p more and the gap will close.

[1sjh] 21/10/2020 12:06

I was recently berated for suggesting a listing price of 75p would be too high.. without some news possibly on c19 trials my price looks more and more likely.

[glasswala] 21/10/2020 12:04

This is ridiculous how has this share price gone below the 1.35 price after the Keytruda results with MRX0518.

[stigofthedump] 21/10/2020 11:20

..and the reason why big brother 8 aint here despite the share price now fallingis because the same person is the stigologist.....who got caught on the bull trap last week and is now doing his futile best to pump this back up tohis entry...

[stigofthedump] 21/10/2020 11:13

all these complaints about aim is a complete red herring - ask holders at sng if they like aim or not...hasnt done them any harm..point is market is now marking this backdown for a reason

[blueblood] 21/10/2020 11:10

Hope they are getting on with it and release details following interest from Cancer updates next month

[devonlad] 21/10/2020 10:32

Totally agree smtmh, they need to raise on the nasdaq if they are going to and get of AIM.

[showmethemoneyhoney01] 21/10/2020 09:48

I think even if we hit a milestone with Merck, we will still want to provide liquidity and get some American institutional investors on board so a fund raise will still need to be done in the US imo. No bad thing. Can never have enough money to progress the opportunities DDDD have.

[devonlad] 21/10/2020 09:35

Just got back from a walk and funnily enough, I was thinking the same thing, they will probably raise when moving to the Nasdaq, sooner the better imho. There is always the chance of Merck paying up as milestones are hit with the $1bn deal. You would have thought that they would have set the milestones at achievable objectives on a given timeline that don't impose financial stress on the business. I have a gut feeling that will come sooner rather than later. Got to pop out again, bloody rain!

[hodr] 21/10/2020 09:26

I agree and this is supported by July placing RNS - all signs point to Feb 2021 and likely 4D will announce Nasdaq listing in Late Nov/Dec 2020. Then start the required quiet period before being listed in Q1 2021 and funding received. 3. USE OF PROCEEDSThe net proceeds of the Fundraising, together with existing cash resources, are anticipated to provide the Company with sufficient working capital through to February 2021. During the period to this time, the Company expects to announce the following key data readouts:· Blautix® Phase II IBS top line results from all study subjects (approximately 370 patients) in Q3 2020;· MRx-4DP0004 Phase II COVID-19 trial top line results in Q4 2020;· comprehensive clinical benefit data for all patients in Part A of MRx0518 Phase I/II open-label combination study with Keytruda®, expected in Q4 2020; and· preliminary results from MRx0518 Phase I clinical biomarker study as a neoadjuvant monotherapy in patients undergoing surgical resection of solid tumours in H2 2020.In addition, initial data from Part B of the MRx0518 Phase I/II open-label combination study with Keytruda®, will be announced as appropriate during the period to February 2021.COVID-19 continues to pose delays to patient recruitment and therefore the timelines of the above readouts are subject to change; in the event of such changes the Company will update the market accordingly.Further to these readouts, the net proceeds of the Fundraising will also be used to strengthen the Company's balance sheet to enable it to explore longer-term strategies including those relating to funding (including the investigation of options for a US listing), out-licensing and potential partnering in relation to pipeline products or platform opportunities, as well as for general working capital purposes.

[amaretto1] 21/10/2020 09:24

Hi Stig :-)

[blueblood] 21/10/2020 09:04

Absolutely agree any funding should be raised as part of Nasdaq listing

[showmethemoneyhoney01] 21/10/2020 08:54

They will need liquidity for a Nasdaq listing. IMO funds will be raised then. At what price, who really cares, the market will dictate that.